The pro-inflammatory role of TGFβ1: a paradox?

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 3258562)

Published in Int J Biol Sci on January 01, 2012

Authors

Gangwen Han1, Fulun Li, Tej Pratap Singh, Peter Wolf, Xiao-Jing Wang

Author Affiliations

1: Department of Pathology, University of Colorado Denver, Aurora, CO 80045, USA.

Articles citing this

Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation. Cytokine Growth Factor Rev (2013) 1.08

Systemic attenuation of the TGF-β pathway by a single drug simultaneously rejuvenates hippocampal neurogenesis and myogenesis in the same old mammal. Oncotarget (2015) 1.03

Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. ScientificWorldJournal (2014) 1.03

Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS One (2013) 0.99

Gene expression profiling and secretome analysis differentiate adult-derived human liver stem/progenitor cells and human hepatic stellate cells. PLoS One (2014) 0.87

Do reciprocal interactions between cell stress proteins and cytokines create a new intra-/extra-cellular signalling nexus? Cell Stress Chaperones (2013) 0.84

Fibromodulin-deficiency alters temporospatial expression patterns of transforming growth factor-β ligands and receptors during adult mouse skin wound healing. PLoS One (2014) 0.84

Leukocytes: The Double-Edged Sword in Fibrosis. Mediators Inflamm (2015) 0.80

Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology. Int Immunopharmacol (2012) 0.80

Mitotic Diversity in Homeostatic Human Interfollicular Epidermis. Int J Mol Sci (2016) 0.79

Identification of a novel PPARβ/δ/miR-21-3p axis in UV-induced skin inflammation. EMBO Mol Med (2016) 0.78

Hypothyroidism and its rapid correction alter cardiac remodeling. PLoS One (2014) 0.78

TGF-β enhanced IL-21-induced differentiation of human IL-21-producing CD4+ T cells via Smad3. PLoS One (2013) 0.78

An integrative modeling framework reveals plasticity of TGF-β signaling. BMC Syst Biol (2014) 0.76

Anti-inflammatory effect of Yu-Ping-Feng-San via TGF-β1 signaling suppression in rat model of COPD. Iran J Basic Med Sci (2016) 0.75

Chymase inhibitor TY-51469 in therapy of inflammatory bowel disease. World J Gastroenterol (2016) 0.75

Tissue-engineered endometrial model for the study of cell-cell interactions. Reprod Sci (2014) 0.75

Cinobufagin Modulates Human Innate Immune Responses and Triggers Antibacterial Activity. PLoS One (2016) 0.75

Potential of targeting TGF-β for organ transplant patients. Future Med Chem (2013) 0.75

The aryl hydrocarbon receptor agonist benzo(a)pyrene reactivates LINE-1 in HepG2 cells through canonical TGF-β1 signaling: implications in hepatocellular carcinogenesis. Am J Cancer Res (2016) 0.75

Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells. PLoS One (2017) 0.75

Expansion of CD11b(+)Ly6G(high) and CD11b(+)CD49d(+) myeloid cells with suppressive potential in mice with chronic inflammation and light-at-night-induced circadian disruption. Inflamm Res (2017) 0.75

Articles cited by this

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity (2006) 29.29

Transforming growth factor-beta induces development of the T(H)17 lineage. Nature (2006) 25.91

IL-17 and Th17 Cells. Annu Rev Immunol (2009) 23.02

Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature (1992) 16.46

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 16.03

Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol (2007) 12.76

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet (2009) 9.45

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol (2002) 9.30

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature (2010) 7.50

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol (2004) 7.41

A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol (2008) 6.09

Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet (2009) 5.93

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med (2007) 5.39

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet (2008) 5.32

Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol (2007) 4.90

Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol (2008) 4.18

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet (2008) 4.06

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med (2004) 4.02

The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol (2009) 3.93

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med (2007) 3.68

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet (2009) 3.55

Skin immune sentinels in health and disease. Nat Rev Immunol (2009) 3.52

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol (2008) 3.22

Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol (2008) 3.11

IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A (2008) 3.04

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med (2010) 2.74

Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol (2005) 2.49

In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol (2006) 2.44

A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today (1998) 2.19

Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol (2003) 2.05

Transforming growth factor beta: a matter of life and death. J Leukoc Biol (1994) 1.97

Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J Clin Invest (2009) 1.95

Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. Trends Immunol (2004) 1.92

Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol (2009) 1.90

Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J (2004) 1.75

Mast cells in atopic dermatitis. Curr Opin Immunol (2009) 1.63

Cutting edge: A critical functional role for IL-23 in psoriasis. J Immunol (2010) 1.61

Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J Immunol (2002) 1.50

Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol (2009) 1.48

Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One (2011) 1.41

Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol (1995) 1.39

A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice. J Clin Invest (1997) 1.35

Latent TGF-beta1 protects against crescentic glomerulonephritis. J Am Soc Nephrol (2008) 1.33

Differentiation of human T(H)-17 cells does require TGF-beta! Nat Immunol (2008) 1.27

8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J Immunol (2010) 1.13

A role for Th17 cells in the immunopathogenesis of atopic dermatitis? J Invest Dermatol (2008) 0.99

Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris. Acta Dermatovenerol Croat (2004) 0.97

TGFbeta1-induced inflammation in premalignant epidermal squamous lesions requires IL-17. J Invest Dermatol (2010) 0.96

Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions. Cytokine (2002) 0.95

Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway. J Invest Dermatol (2009) 0.93

Plasma TGF-beta1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity. Biomarkers (2008) 0.92

Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice. Am J Pathol (2011) 0.92

Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy (2004) 0.91

Systemic ciclosporin and tacrolimus in dermatology. Dermatol Ther (2007) 0.89

p53 and Fas ligand are required for psoralen and UVA-induced apoptosis in mouse epidermal cells. Cell Death Differ (2002) 0.87

A role for TGFbeta signaling in the pathogenesis of psoriasis. J Invest Dermatol (2009) 0.87

Plasma transforming growth factor beta1 as a biomarker of psoriasis activity and treatment efficacy. Biomarkers (2003) 0.86

Inflammation and TGF beta 1: lessons from the TGF beta 1 null mouse. Res Immunol (1997) 0.86

Breach delivery: increased solute uptake points to a defective skin barrier in atopic dermatitis. J Invest Dermatol (2007) 0.83

Langerhans cells in the TGF beta 1 null mouse. Adv Exp Med Biol (1997) 0.83

Facing psoriasis and atopic dermatitis: are there more similarities or more differences? Eur J Dermatol (2008) 0.83

T helper 1 to T helper 2 shift in cytokine expression: an autoregulatory process in superantigen-associated psoriasis progression? J Med Microbiol (2009) 0.79

Articles by these authors

CIP2A inhibits PP2A in human malignancies. Cell (2007) 5.28

Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med (2011) 4.68

Mechanisms of gamma oscillations. Annu Rev Neurosci (2012) 4.58

A recurrent network mechanism of time integration in perceptual decisions. J Neurosci (2006) 4.53

Cortico-basal ganglia circuit mechanism for a decision threshold in reaction time tasks. Nat Neurosci (2006) 4.36

What determines the frequency of fast network oscillations with irregular neural discharges? I. Synaptic dynamics and excitation-inhibition balance. J Neurophysiol (2003) 3.54

Neuronal basis of age-related working memory decline. Nature (2011) 3.15

The importance of mixed selectivity in complex cognitive tasks. Nature (2013) 3.05

Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res (2007) 3.02

Cellular and network mechanisms of slow oscillatory activity (<1 Hz) and wave propagations in a cortical network model. J Neurophysiol (2003) 2.92

Standardized computer-based organized reporting of EEG: SCORE. Epilepsia (2013) 2.84

Interneuron Diversity series: Circuit complexity and axon wiring economy of cortical interneurons. Trends Neurosci (2004) 2.68

NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex. Neuron (2013) 2.46

Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Dev (2006) 2.46

Variance as a signature of neural computations during decision making. Neuron (2011) 2.42

Smad7-induced beta-catenin degradation alters epidermal appendage development. Dev Cell (2006) 2.41

Two calcium-dependent protein kinases, CPK4 and CPK11, regulate abscisic acid signal transduction in Arabidopsis. Plant Cell (2007) 2.40

The role of default network deactivation in cognition and disease. Trends Cogn Sci (2012) 2.39

Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet (2011) 2.32

Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol (2007) 2.09

Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest (2005) 1.98

Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J Clin Invest (2009) 1.95

Similarity effect and optimal control of multiple-choice decision making. Neuron (2008) 1.88

Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest (2008) 1.88

Augmented visual, auditory, haptic, and multimodal feedback in motor learning: a review. Psychon Bull Rev (2013) 1.86

Robust spatial working memory through homeostatic synaptic scaling in heterogeneous cortical networks. Neuron (2003) 1.85

Neural circuit dynamics underlying accumulation of time-varying evidence during perceptual decision making. Front Comput Neurosci (2007) 1.85

Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol (2004) 1.77

Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J (2004) 1.75

A biophysically based neural model of matching law behavior: melioration by stochastic synapses. J Neurosci (2006) 1.72

Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res (2004) 1.71

The stability of a stochastic CaMKII switch: dependence on the number of enzyme molecules and protein turnover. PLoS Biol (2005) 1.70

Neural dissociation of delay and uncertainty in intertemporal choice. J Neurosci (2008) 1.68

Transforming growth factor-β signaling promotes pulmonary hypertension caused by Schistosoma mansoni. Circulation (2013) 1.68

A reservoir of time constants for memory traces in cortical neurons. Nat Neurosci (2011) 1.66

A recurrent network model of somatosensory parametric working memory in the prefrontal cortex. Cereb Cortex (2003) 1.66

IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci U S A (2008) 1.66

A specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex. Proc Natl Acad Sci U S A (2008) 1.61

T1799A BRAF mutation is common in PUVA lentigines. J Invest Dermatol (2006) 1.59

A neural circuit model of flexible sensorimotor mapping: learning and forgetting on multiple timescales. Neuron (2007) 1.56

Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol (2004) 1.46

Contributions of intrinsic membrane dynamics to fast network oscillations with irregular neuronal discharges. J Neurophysiol (2005) 1.42

Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One (2011) 1.41

Temporally irregular mnemonic persistent activity in prefrontal neurons of monkeys during a delayed response task. J Neurophysiol (2003) 1.41

Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis. Arch Dermatol (2007) 1.40

Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res (2004) 1.40

Angular path integration by moving "hill of activity": a spiking neuron model without recurrent excitation of the head-direction system. J Neurosci (2005) 1.39

Internal representation of task rules by recurrent dynamics: the importance of the diversity of neural responses. Front Comput Neurosci (2010) 1.37

Synaptic computation underlying probabilistic inference. Nat Neurosci (2009) 1.36

Mean-driven and fluctuation-driven persistent activity in recurrent networks. Neural Comput (2007) 1.35

NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc Natl Acad Sci U S A (2012) 1.32

The dynamical stability of reverberatory neural circuits. Biol Cybern (2002) 1.30

Proactive inhibitory control and attractor dynamics in countermanding action: a spiking neural circuit model. J Neurosci (2009) 1.29

A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. Mol Oncol (2013) 1.28

A neural circuit basis for spatial working memory. Neuroscientist (2004) 1.28

An integrated microcircuit model of attentional processing in the neocortex. J Neurosci (2007) 1.28

Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. EMBO J (2002) 1.25

Cognitive and cognitive-motor interventions affecting physical functioning: a systematic review. BMC Geriatr (2011) 1.23

The dynamical response properties of neocortical neurons to temporally modulated noisy inputs in vitro. Cereb Cortex (2008) 1.22

Essential roles of BMPR-IA signaling in differentiation and growth of hair follicles and in skin tumorigenesis. Genesis (2004) 1.22

From distributed resources to limited slots in multiple-item working memory: a spiking network model with normalization. J Neurosci (2012) 1.20

Inhibitory control by an integral feedback signal in prefrontal cortex: a model of discrimination between sequential stimuli. Proc Natl Acad Sci U S A (2005) 1.20

Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proc Natl Acad Sci U S A (2009) 1.20

Overexpression of microRNA OsmiR397 improves rice yield by increasing grain size and promoting panicle branching. Nat Biotechnol (2013) 1.20

Bursting neurons signal input slope. J Neurosci (2002) 1.17

Neural mechanism for stochastic behaviour during a competitive game. Neural Netw (2006) 1.15

In utero activation of K5.CrePR1 induces gene deletion. Genesis (2002) 1.14

8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J Immunol (2010) 1.13

Abscisic acid stimulates a calcium-dependent protein kinase in grape berry. Plant Physiol (2006) 1.12

Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol (2008) 1.12

Imaging seizure activity: a combined EEG/EMG-fMRI study in reading epilepsy. Epilepsia (2008) 1.12

Psoriasis alters HDL composition and cholesterol efflux capacity. J Lipid Res (2012) 1.11

Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer. Cancer Res (2009) 1.11

Same or different? A neural circuit mechanism of similarity-based pattern match decision making. J Neurosci (2011) 1.09

Linking microcircuit dysfunction to cognitive impairment: effects of disinhibition associated with schizophrenia in a cortical working memory model. Cereb Cortex (2012) 1.09

CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitis. J Invest Dermatol (2012) 1.08

MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol (2012) 1.07

Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Arch Dermatol (2006) 1.07

Mouse models for human head and neck squamous cell carcinomas. Head Neck (2006) 1.07

Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer. Cancer Res (2013) 1.06

MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines. Int J Biol Sci (2011) 1.06

K14-GLp65 transactivator induces transgene expression in embryonic epidermis. Genesis (2002) 1.06

Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol (2007) 1.06

Cannabinoid-mediated disinhibition and working memory: dynamical interplay of multiple feedback mechanisms in a continuous attractor model of prefrontal cortex. Cereb Cortex (2007) 1.06

Epidermal Smad4 deletion results in aberrant wound healing. Am J Pathol (2009) 1.06

Lichen aureus: clinicopathologic features, natural history, and relationship to mycosis fungoides. Arch Dermatol (2008) 1.05

Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis. Cancer Res (2004) 1.05

The role of Smads in skin development. J Invest Dermatol (2008) 1.04

CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma. J Invest Dermatol (2004) 1.04

Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice. J Clin Invest (2009) 1.03

The Arabidopsis Ca(2+) -dependent protein kinase CPK12 negatively regulates abscisic acid signaling in seed germination and post-germination growth. New Phytol (2011) 1.03

Roles of TGFβ signaling Smads in squamous cell carcinoma. Cell Biosci (2011) 1.02

Tuning curve shift by attention modulation in cortical neurons: a computational study of its mechanisms. Cereb Cortex (2005) 1.02

Power-law neuronal fluctuations in a recurrent network model of parametric working memory. J Neurophysiol (2005) 1.01

Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. J Clin Invest (2013) 1.01

Reconciling coherent oscillation with modulation of irregular spiking activity in selective attention: gamma-range synchronization between sensory and executive cortical areas. J Neurosci (2010) 1.00

Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS One (2013) 0.99